# A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

> **NCT04779320** · PHASE3 · RECRUITING · sponsor: **Takeda** · enrollment: 120 (estimated)

## Conditions studied

- Crohn's Disease (CD)

## Interventions

- **DRUG:** Vedolizumab IV

## Key facts

- **NCT ID:** NCT04779320
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-02-10
- **Primary completion:** 2027-09-13
- **Final completion:** 2027-09-13
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04779320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04779320, "A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04779320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*